TY - JOUR
T1 - A retrospective study of parotid gland tumors at a single institution
AU - Suzuki, Shiori
AU - Bandoh, Nobuyuki
AU - Goto, Takashi
AU - Kubota, Akinobu
AU - Uemura, Akihiro
AU - Kono, Michihisa
AU - Sato, Ryosuke
AU - Takeda, Ryuhei
AU - Sakaue, Shota
AU - Yamaguchi-Isochi, Tomomi
AU - Nishihara, Hiroshi
AU - Takei, Hidehiro
AU - Harabuchi, Yasuaki
N1 - Funding Information:
The authors would like to thank Professor Mitsuru Sekido (Department of Plastic and Reconstructive Surgery, University of Tsukuba, Tsukuba, Japan) and Dr Shujiroh Makino (Department of Oral Surgery, Hokuto Hospital, Obihiro, Japan) for performing the reconstruction surgery, and Dr Akihiko Miyamoto (Department of Radiation Therapy, Hokuto Hospital, Obihiro, Japan) and Dr Ken‑Ichi Matsumoto (Department of Radiation Therapy, Hokuto Hospital, Obihiro, Japan) for performing the radiotherapy.
Publisher Copyright:
© 2022 Spandidos Publications. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - The aim of the present study was to analyze the clinical characteristics, surgical treatments and clinical outcome of patients with parotid gland tumors and to compare the results with those cited in the literature. A retrospective study was conducted in 140 patients (male, n=77; female, n=63) with parotid gland tumors who underwent parotidectomy at Hokuto Hospital Department of Otolaryngology-Head and Neck Surgery (Obihiro, Japan) between April 2007 and December 2021. Of the 140 patients enrolled, 118 (84.3%) patients had benign tumors, including 63 (45%) patients with pleomorphic adenomas and 43 (30.7%) patients with Warthin tumors, and 22 patients (15.7%) had parotid carcinoma. Comparison of the three groups of patients with parotid gland tumors indicated that pack years as an indicator of smoking status were signifi‑ cantly higher in patients with Warthin tumors than in those with parotid carcinomas (P=0.011) or pleomorphic adenoma (P<0.001). Fine‑needle aspiration cytology (FNAC) was non‑diagnostic for only 6 (4.3%) of 140 patients. The sensi‑ tivity, specificity, positive predictive value, negative predictive value and accuracy of FNAC by both conventional smear and liquid‑based cytology (LBC) for parotid carcinomas were 70, 99, 93.3, 94.4 and 82.9%, respectively. Among the 22 patients with parotid carcinoma, extended total/total and superficial parotidectomy were performed in 10 (45%) and 11 (50%) cases, respectively. Total and selective neck dissection of the area from level II to I, II and III were performed in 6 (24%) and 7 (32%) patients, respectively. Postoperative radiotherapy (50 Gy) was performed in 15 (68%) patients. The overall survival (OS) and disease‑free survival (DFS) rates at 5 years were 51.5 and 76.4%, respectively. Univariate analysis revealed that age >65 years was significantly associated with poorer 5‑year OS (P<0.001) and DFS (P<0.001). Multivariate analysis revealed that an age of more than 65 years combined with high‑grade histologic malignancy was associated with worse DFS (P=0.02; hazard ratio, 3.628; 95% confidence interval, 1.283-9.514). In conclusion, the clinical characteristics and treatment outcomes of parotid gland tumors were consistent with the results of previous reports. Smoking may be closely related to the pathogenesis of Warthin tumors. LBC potentially provides improved accuracy in FNAC.
AB - The aim of the present study was to analyze the clinical characteristics, surgical treatments and clinical outcome of patients with parotid gland tumors and to compare the results with those cited in the literature. A retrospective study was conducted in 140 patients (male, n=77; female, n=63) with parotid gland tumors who underwent parotidectomy at Hokuto Hospital Department of Otolaryngology-Head and Neck Surgery (Obihiro, Japan) between April 2007 and December 2021. Of the 140 patients enrolled, 118 (84.3%) patients had benign tumors, including 63 (45%) patients with pleomorphic adenomas and 43 (30.7%) patients with Warthin tumors, and 22 patients (15.7%) had parotid carcinoma. Comparison of the three groups of patients with parotid gland tumors indicated that pack years as an indicator of smoking status were signifi‑ cantly higher in patients with Warthin tumors than in those with parotid carcinomas (P=0.011) or pleomorphic adenoma (P<0.001). Fine‑needle aspiration cytology (FNAC) was non‑diagnostic for only 6 (4.3%) of 140 patients. The sensi‑ tivity, specificity, positive predictive value, negative predictive value and accuracy of FNAC by both conventional smear and liquid‑based cytology (LBC) for parotid carcinomas were 70, 99, 93.3, 94.4 and 82.9%, respectively. Among the 22 patients with parotid carcinoma, extended total/total and superficial parotidectomy were performed in 10 (45%) and 11 (50%) cases, respectively. Total and selective neck dissection of the area from level II to I, II and III were performed in 6 (24%) and 7 (32%) patients, respectively. Postoperative radiotherapy (50 Gy) was performed in 15 (68%) patients. The overall survival (OS) and disease‑free survival (DFS) rates at 5 years were 51.5 and 76.4%, respectively. Univariate analysis revealed that age >65 years was significantly associated with poorer 5‑year OS (P<0.001) and DFS (P<0.001). Multivariate analysis revealed that an age of more than 65 years combined with high‑grade histologic malignancy was associated with worse DFS (P=0.02; hazard ratio, 3.628; 95% confidence interval, 1.283-9.514). In conclusion, the clinical characteristics and treatment outcomes of parotid gland tumors were consistent with the results of previous reports. Smoking may be closely related to the pathogenesis of Warthin tumors. LBC potentially provides improved accuracy in FNAC.
KW - Warthin tumor
KW - facial nerve palsy
KW - fine-needle aspiration cytology
KW - mucoepidermoid carcinoma
KW - parotid carcinoma
KW - pleomorphic adenoma
UR - http://www.scopus.com/inward/record.url?scp=85133280953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133280953&partnerID=8YFLogxK
U2 - 10.3892/OL.2022.13328
DO - 10.3892/OL.2022.13328
M3 - Article
AN - SCOPUS:85133280953
SN - 1792-1074
VL - 24
JO - Oncology Letters
JF - Oncology Letters
IS - 1
M1 - 207
ER -